Niedrobnokomórkowy rak płuca: badanie fazy III leku cisplatin i BAY 2927088
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC)…